SCHEMBL8416338

SCHEMBL8416338

Cc1nc2ccccc2n1CCCCN1CCN(c2ncccn2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.63
LMNA P02545 2/20 0.58
HTR1A P08908 9/20 0.54
HTR7 P34969 7/20 0.54
DRD2 P14416 5/20 0.54
HTR2A P28223 4/20 0.54
DRD3 P35462 3/20 0.54
DRD4 P21917 2/20 0.54
TP53 P04637 1/20 0.53
HTT P42858 1/20 0.53
ADRA2A P08913 1/20 0.52
ADRA2C P18825 1/20 0.52
SLC6A2 P23975 1/20 0.52
ADRA1A P35348 1/20 0.52
HRH1 P35367 1/20 0.52
HTR2B P41595 1/20 0.52
SIGMAR1 Q99720 1/20 0.52
DRD1 P21728 1/20 0.48
DRD5 P21918 1/20 0.48
GRM2 Q14416 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8418007 0.85 HTR1A (0.54) LMNAHTR1AHTR7DRD2HTR2A
SCHEMBL7081243 0.82 HTR7 (0.67) P2RX7LMNAHTR1AHTR7DRD2
SCHEMBL8417626 0.82 FAAH (0.51) P2RX7HTR1AHTR7DRD2HTR2A
SCHEMBL17192201 0.80 KCNH2 (0.64) P2RX7LMNAHTR1AHTR7DRD2
SCHEMBL2330274 0.78 LMNA (0.69) P2RX7LMNATP53HTT
SCHEMBL8418064 0.78 HTR1A (0.59) HTR1AHTR7DRD2HTR2ADRD3
SCHEMBL8418004 0.78 HTR1A (0.48) HTR1AHTR7DRD2HTR2ADRD3
SCHEMBL11198955 0.77 P2RX7 (1.00) P2RX7LMNA
SCHEMBL8417646 0.76 SOAT1 (0.49) P2RX7HTR1AHTR7DRD2HTR2A
SCHEMBL8418073 0.76 DRD2 (0.70) P2RX7LMNAHTR1AHTR7DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0497659-B1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs ESTEVE LABOR DR (ES) 1996-04-10 EP claimed
EP-0655248-A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1995-05-31 EP claimed
EP-0502786-A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-09-09 EP claimed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP claimed